Literature DB >> 15290428

Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer.

Hiromichi Ishiyama1, Akiko Shibata, Keiji Niino, Takaaki Hosoya.   

Abstract

To determine whether radiotherapy is effective for reducing morphine dose in patients with bone metastasis from lung cancer, a retrospective study was undertaken of 58 patients who had undergone palliative radiotherapy. Mean dose of radiotherapy was 20.26 (range 8-60) Gy. Daily morphine dose after start of radiotherapy was significantly greater than before radiotherapy, and dose of morphine did not significantly decrease. Radiotherapy appears ineffective for reducing morphine dose in patients with bone metastasis from lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290428     DOI: 10.1007/s00520-004-0625-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  8 in total

1.  How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial.

Authors:  P Allard; C Lamontagne; P Bernard; C Tremblay
Journal:  J Pain Symptom Manage       Date:  1999-04       Impact factor: 3.612

Review 2.  Bone metastasis: review and critical analysis of random allocation trials of local field treatment.

Authors:  V Ratanatharathorn; W E Powers; W T Moss; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

Review 3.  A systematic overview of radiation therapy effects in skeletal metastases.

Authors:  Ursula Falkmer; Johannes Järhult; Peter Wersäll; Eva Cavallin-Ståhl
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

Review 4.  Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

Authors:  Jackson Sai-Yiu Wu; Rebecca Wong; Mary Johnston; Andrea Bezjak; Timothy Whelan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

5.  Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases.

Authors:  Thomas P Shakespeare; Jiade J Lu; Michael F Back; Shen Liang; Rahul K Mukherjee; Christopher J Wynne
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

6.  Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.

Authors:  O S Nielsen; S M Bentzen; E Sandberg; C C Gadeberg; A R Timothy
Journal:  Radiother Oncol       Date:  1998-06       Impact factor: 6.280

7.  A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain.

Authors:  B Jeremic; Y Shibamoto; L Acimovic; B Milicic; S Milisavljevic; N Nikolic; J Aleksandrovic; I Igrutinovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

Review 8.  Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.

Authors:  W M Sze; M D Shelley; I Held; T J Wilt; M D Mason
Journal:  Clin Oncol (R Coll Radiol)       Date:  2003-09       Impact factor: 4.126

  8 in total
  4 in total

1.  Radiotherapy, morphine, and bone pain: a difficult relationship?

Authors:  Alberto Sbanotto; Maria Banfi; Daniela Alterio; Andrea Rocca
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

2.  Palliative treatment of multiple bone metastasis.

Authors:  Meagan Doyle; Elizabeth A Barnes; Emily Sinclair; Cyril Danjoux; Edward Chow
Journal:  Support Care Cancer       Date:  2005-01-12       Impact factor: 3.603

3.  Scoring the effect of radiotherapy for painful bone metastases.

Authors:  Sebastiano Mercadante
Journal:  Support Care Cancer       Date:  2006-03-30       Impact factor: 3.603

4.  Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine.

Authors:  Giovanni Carlo Anselmetti
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.